Ocular Melanoma Information and Resources: Causes, Insights, and Treatment Options

Ocular melanoma is the most common primary intraocular malignancy in adults, originating in the choroid, the vascular layer of the eye. Though rare, it is a serious condition that requires timely diagnosis and treatment. Understanding its causes, symptoms, and available treatment options is essential for patients and caregivers navigating this condition. This blog provides an in-depth look at ocular melanoma, including risk factors, symptoms, diagnostic methods, treatments, and available resources.

What is Ocular Melanoma?

​Ocular melanoma is a type of uveal melanoma that affects the pigmented cells in the choroid. The choroid is responsible for supplying oxygen and nutrients to the retina, making it a crucial component of eye health. The tumors develop from melanocytes, the same type of cells responsible for skin pigmentation. While the exact cause remains unclear, research continues to uncover genetic and environmental factors contributing to this rare but serious condition. According to the American Society of Retina Specialists, ocular melanoma affects approximately 2,500 people per year in the United States, with an incidence of 6 per million.

Causes and Risk Factors

The exact cause of ocular melanoma is not fully understood, but several risk factors may increase susceptibility:

• Genetic Factors: Mutations in genes such as GNAQ and GNA11 have been linked to the development of uveal melanoma. Genetic testing may help identify individuals at a higher risk.
• Fair Skin and Light Eye Color: Individuals with light-colored eyes (blue or green) and fair skin are at a higher risk. Melanin may provide some protective effects against the development of ocular melanoma.
• Ultraviolet (UV) Exposure: While the link between UV exposure and ocular melanoma is still debated, excessive UV radiation may contribute to an increased risk. Wearing UV-blocking sunglasses may help reduce potential risks.
• Age and Gender: Ocular melanoma is more commonly diagnosed in individuals over 50, with a slightly higher prevalence in men.
• Certain Occupational Exposures: Some studies suggest that individuals exposed to certain chemicals or radiation in the workplace may have an increased risk of developing ocular melanoma.
• Family History: A history of uveal melanoma in close family members may indicate a genetic predisposition, although the hereditary component of this disease is still being studied.

Symptoms of Ocular Melanoma

Early-stage ocular melanoma often presents without noticeable symptoms, making regular eye exams crucial for detection. As the tumor grows, symptoms may include:

• Blurred or distorted vision
• Floaters or flashes of light
• A dark spot in the visual field
• Vision loss in one eye
• Changes in the shape of the pupil
• Increased intraocular pressure (in some cases)

If any of these symptoms occur, an immediate ophthalmologic evaluation is necessary. Since many symptoms can also indicate less severe eye conditions, proper diagnosis is key to determining the cause.

Diagnosis

Diagnosing ocular melanoma requires comprehensive eye examinations and imaging techniques, such as:

• Dilated Fundus Exam: An ophthalmologist examines the retina and choroid for abnormalities.
• Ultrasound Imaging: Helps determine tumor size, shape, and location. Ultrasound can also assess the density of the tumor, which aids in distinguishing melanoma from other intraocular lesions.
• Optical Coherence Tomography (OCT): Provides cross-sectional images of the retina and choroid to assess tumor effects on adjacent structures.
• Fluorescein Angiography: Evaluates blood flow in the eye and identifies abnormal vascular patterns associated with tumors.
• Biopsy (in rare cases): Used when imaging results are inconclusive. Biopsies may also provide information about the tumor’s genetic characteristics and metastatic potential.
• Magnetic Resonance Imaging (MRI) or Computed Tomography (CT): Used to check for metastases or assess extraocular extension in advanced cases.

Treatment Options for Ocular Melanoma

Treatment for ocular melanoma depends on the tumor size, location, and the patient’s overall health. Common treatment approaches include:

Radiation Therapy

• Plaque Brachytherapy: A small radiation plaque is surgically placed on the eye near the tumor, delivering targeted radiation over several days. This treatment is commonly used for medium-sized tumors and aims to preserve vision when possible.
• Proton Beam Radiation: A highly precise form of radiation therapy that minimizes damage to surrounding tissue. Proton therapy has gained popularity due to its ability to effectively target the tumor while sparing healthy eye structures.

Surgical Interventions

• Enucleation: Complete removal of the eye is considered when the tumor is too large or if vision cannot be preserved. This procedure is often recommended for large tumors or cases where the eye is painful and nonfunctional.
• Local Tumor Resection: In some cases, the tumor may be surgically removed while preserving the eye, though this approach is less common due to the complexity of the procedure.

Laser and Drug Therapies

• Photocoagulation and Thermotherapy: Laser treatments used in specific cases to shrink the tumor. These are sometimes used in combination with other treatments.
• Emerging Immunotherapy and Targeted Therapy: Research is ongoing into therapies that may enhance treatment outcomes. Immunotherapy and targeted drugs are being explored for cases where ocular melanoma has metastasized.

Prognosis and Follow-up Care

The prognosis for ocular melanoma varies depending on tumor size and metastasis. When diagnosed early, localized treatment can be highly effective, and many patients maintain partial or full vision in the affected eye. However, because ocular melanoma can metastasize, particularly to the liver, ongoing monitoring with imaging and blood tests is essential.

Follow-up care typically includes:

• Regular ophthalmologic exams to monitor for tumor recurrence
• Liver function tests and imaging scans to check for metastasis
• Genetic testing in some cases to assess metastatic risk

For patients whose cancer has metastasized, systemic therapies and clinical trials may provide additional treatment options.

Resources and Support for Ocular Melanoma

Navigating a ocular melanoma diagnosis can be overwhelming, but numerous resources are available to provide guidance, support, and information:

• Ocular Melanoma Foundation (OMF): Provides resources, patient support, and funds research initiatives.
• A Cure in Sight: Support organization for ocular melanoma patients
• The Melanoma Research Foundation: Has resources specific to ocular melanoma
• EyeMelanoma.org – Reference guide for accessing ocular melanoma patient support resources and online educational materials
• National Organization for Rare Disorders (NORD): Offers financial assistance for medication costs, insurance copays, travel for treatment, and emergency needs for rare disease patients.
• Ocular Melanoma Friends & Family – A community offering peer-to-peer support, shared experiences, and resources for those affected by ocular melanoma.

Engaging with these organizations can help patients navigate their diagnosis, connect with specialists, and find support networks.

Conclusion

Ocular melanoma is a rare but serious eye cancer that requires prompt diagnosis and treatment. Regular eye exams, awareness of risk factors, and staying informed about treatment options can significantly improve outcomes. While the diagnosis can be overwhelming, advancements in radiation, surgery, and emerging therapies continue to improve survival rates and quality of life. If you or a loved one has been diagnosed with ocular melanoma, seek guidance from ophthalmologists, oncologists, and patient support organizations for the best care and support available. 

To explore clinical trial opportunities, visit the Leapcure website here to share your Ocular Melanoma story and be considered for participation.